Clinical Trial

the ANRS CO21 " Extreme " Cohort (CODEX)

Study acronym: CODEX
Recruiting
View on ClinicalTrials.gov →
Summary
A consortium of research teams has studied the immunovirological characteristics of these patients: The ANRS CO15 ALT cohort The ANRS CO18 HIV Controller cohort the ANRS EP47 VISCONTI study
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2012-01-26; most recent amendment 2026-04-02.
Status change: Not Yet Recruiting → Recruiting 2012-12-26
Trial Details
NCT Number NCT01520844
Lead Sponsor ANRS, Emerging Infectious Diseases
Conditions HIV Infection
Enrollment 450 participants
Start Date 2012-02
Primary Completion 2029-09 (estimated)
Study Completion 2030-09 (estimated)
Updated on ClinicalTrials.gov 2026-04-07